| Bioactivity | VU0080241 is a positive allosteric modulator (PAM) of the metabotropic glutamate receptor subtype 4 (mGluR4), with an EC50 of 4.6 μM[1]. | |||||||||
| Name | VU0080241 | |||||||||
| CAS | 393845-24-4 | |||||||||
| Formula | C19H23N5 | |||||||||
| Molar Mass | 321.42 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Colleen M Niswender, et al. Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4): Part I. Discovery of pyrazolo[3,4-d]pyrimidines as novel mGluR4 positive allosteric modulators. Bioorg Med Chem Lett. 2008 Oct 15; 18(20) |
VU0080241
CAS: 393845-24-4 F: C19H23N5 W: 321.42
VU0080241 is a positive allosteric modulator (PAM) of themetabotropic glutamate receptor subtype 4 (mGluR4), with an EC5
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.